Integrate Computational Biology, Generative AI & Machine Learning to Revolutionize Biologics Drug Discovery & Development
October 22-24, 2024 | Boston, MA
Welcome to the 9th CDD for Biologics Summit
For the past eight years, the CDD for Biologics Summit has united computational and structural biologists, along with protein and antibody engineers, to showcase emerging computational programs and models aimed at revolutionizing biologics drug discovery and development.
With the transformative impact of AI-driven approaches in enhancing predictability, optimizing molecular design, and mitigating inherent risks in drug development pipelines, the summit is an indispensable platform for industry leaders to collaborate, innovate, and propel drug discovery forward amidst this era of computational excellence.
The 9th annual event returns to Boston in 2024, continuing to support drug developers of all sizes in advancing their novel biotherapeutics discovery and development. Join us to dive into the latest industry innovations, highlighting methods and best practices to automate and streamline data collection, integrate experimental data, and leverage state-of-the-art deep learning models for the progression of novel, complex biologics pipelines.
Expert Speakers Include:
Prashanth Vishwanath
Director and Head Of Biologics Informatics & Automation
Takeda Pharmaceutical Co. Ltd.
Hear What Previous Attendees Have to Say:
“This meeting will provide me with an opportunity to be updated with the latest work in the field and meet like-minded people to discuss science”
“By fostering an environment of open communication and collaboration, these conferences provide a platform for the exchange of ideas and best practices, enabling the community to grow and thrive”
“I see immense value in attending the Annual CDD for Biologics Summit. This event provides a unique opportunity to stay abreast of cutting-edge computational methods and best practices in biologics research”
“CDD provides an opportunity to go beyond the hype of AI/ML and discuss with other practitioners in the field the details of what the technology can do today”
